Liu, Z.; Luo, X.; Mo, Y.; Zhao, P.; Wang, H.; Fang, Y.; Xu, Y.
Enzyme-Enhanced Codelivery of Doxorubicin and Bcl-2 Inhibitor by Electrospun Nanofibers for Synergistic Inhibition of Prostate Cancer Recurrence. Pharmaceuticals 2022, 15, 1244.
https://doi.org/10.3390/ph15101244
AMA Style
Liu Z, Luo X, Mo Y, Zhao P, Wang H, Fang Y, Xu Y.
Enzyme-Enhanced Codelivery of Doxorubicin and Bcl-2 Inhibitor by Electrospun Nanofibers for Synergistic Inhibition of Prostate Cancer Recurrence. Pharmaceuticals. 2022; 15(10):1244.
https://doi.org/10.3390/ph15101244
Chicago/Turabian Style
Liu, Zheng, Xing Luo, Yongxin Mo, Pengkai Zhao, Haixia Wang, Youqiang Fang, and Yanteng Xu.
2022. "Enzyme-Enhanced Codelivery of Doxorubicin and Bcl-2 Inhibitor by Electrospun Nanofibers for Synergistic Inhibition of Prostate Cancer Recurrence" Pharmaceuticals 15, no. 10: 1244.
https://doi.org/10.3390/ph15101244
APA Style
Liu, Z., Luo, X., Mo, Y., Zhao, P., Wang, H., Fang, Y., & Xu, Y.
(2022). Enzyme-Enhanced Codelivery of Doxorubicin and Bcl-2 Inhibitor by Electrospun Nanofibers for Synergistic Inhibition of Prostate Cancer Recurrence. Pharmaceuticals, 15(10), 1244.
https://doi.org/10.3390/ph15101244